Dr. Daniels, a native of Detroit, MI, holds nearly a dozen United States patents for his various medical inventions. An Associate Professor in both the departments of Radiology and Oncology, Dr. Daniels’ contributions to the Keck School of Medicine have been profound.
He‘s currently the Director of Endocare and a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Daniels has authored over 100 peer reviewed articles, book chapter and abstracts for influential medical journals. A graduate of Stanford University’s School of Medicine, Dr. Daniels has been a faculty member at the Keck School of Medicine since 1979.
Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. AJR Am J Roentgenol. 2011 Feb; 196(2):W220. View in: PubMed
Subselective intra-arterial chemotherapy infusion in the treatment of hepatocellular carcinoma. Semin Oncol. 2010 Apr; 37(2):83-8. View in: PubMed